| | | | | |
| $31,2600 | -1,73% | $280,50M | $48,75K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | $14,1100 | -0,21% | $280,16M | $14,35K | |
TSI TCW Strategic Income Fund, Inc. | $4,4000 | +0,00% | $279,70M | $134,29K | |
PAII Pyrophyte Acquisition Corp. II | $10,2800 | +0,00% | $279,21M | $1,64K | |
| $15,1400 | +6,25% | $279,07M | $716,79K | |
YDES YD Bio Limited Ordinary Shares | $4,2600 | -8,97% | $279,07M | $11,36K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | $9,9900 | -0,10% | $278,71M | $5,97K | |
RWAY Runway Growth Finance Corp. Common Stock | $6,5400 | -0,31% | $278,70M | $277,26K | |
JILL J.Jill, Inc. Common Stock | $19,8600 | +0,51% | $278,69M | $83,89K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,1299 | -0,01% | $278,19M | $796,23K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | $10,3150 | -0,15% | $278,12M | $69,65K | |
ACV Virtus Diversified Income & Convertible Fund | $26,4300 | -0,49% | $278,09M | $48,77K | |
ALXO ALX Oncology Holdings Inc. Common Stock | $1,9700 | -1,50% | $277,93M | $385,05K | |
| $1,3500 | -6,25% | $277,83M | $760,81K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | $2,9100 | -1,69% | $277,66M | $48,79K | |
